Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis / Q000502:physiology*; D003533:Cyproheptadine / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007003:Hypoglycemia / Q000097:blood; D007031:Hypothalamus / Q000502:physiology; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008784:Methysergide / Q000008:administration & dosage / Q000494:pharmacology*; D011863:Radioimmunoassay; D012701:Serotonin / Q000502:physiology; D012702:Serotonin Antagonists
D001786:Blood Glucose; D007328:Insulin; D012702:Serotonin Antagonists; D003533:Cyproheptadine; D012701:Serotonin; D013006:Growth Hormone; D008784:Methysergide